Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(9):627; doi:10.1093/jnci/97.9.627
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hede, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hede, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

RNA-based Nanoparticle Treatment Shows Promise in Ewing's Sarcoma Model

Karyn Hede

The first 10% of the full text of this article appears below.

If RNA interference is to have any impact on cancer therapy, it will have to pass three tests. It will need to specifically target tumor cells, effectively stop their growth, and do so with few side effects. Now a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?